Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Marsoni

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Cancer Investigation|March 20, 2003
Cancer drug development in Europe: a selection of new agents under development at the European Drug Development NetworkD Lacombe, A Butler-Smith, P Therasse, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
VP16-213 and cyclophosphamide in non oat cell bronchogenic carcinomaL Morasca, S Marsoni, M B Pisoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia OncologicaG Bolis, N Colombo, S Pecorelli, et al.
British Journal of Cancer|September 1, 1990
Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG))S Marsoni, V Torri, M G Valsecchi, et al.
British Journal of Cancer|July 26, 2012
Venous thromboembolism is a relevant and underestimated adverse event in cancer patients treated in phase I studiesM Mandalà, F Grosso, C Vitalini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
The impact of cancer treatment guidelines on actual practice in Italian general hospitals: the case of ovarian cancerR Grilli, A Alexanian, G Apolone, et al.
Cancer Treatment Reports|August 1, 1980
Early phase pharmacokinetics of doxorubicin (adriamycin) in plasma of cancer patients during single- or multiple-drug therapyE Piazza, M G Donelli, M Broggini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Critical review of the quality and development of randomized clinical trials (RCTs) and their influence on the treatment of advanced epithelial ovarian cancerS Marsoni, W Torri, A Taiana, et al.
Tumori|June 30, 1990
Quality of care of colorectal cancer patients in general hospitals: diffusion and impact of management guidelinesG Apolone, R Grilli, A A Alexanian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2018
Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancerS Siena, A Sartore-Bianchi, S Marsoni, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Cancer Investigation|March 20, 2003
Cancer drug development in Europe: a selection of new agents under development at the European Drug Development NetworkD Lacombe, A Butler-Smith, P Therasse, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
VP16-213 and cyclophosphamide in non oat cell bronchogenic carcinomaL Morasca, S Marsoni, M B Pisoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia OncologicaG Bolis, N Colombo, S Pecorelli, et al.
British Journal of Cancer|September 1, 1990
Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG))S Marsoni, V Torri, M G Valsecchi, et al.
British Journal of Cancer|July 26, 2012
Venous thromboembolism is a relevant and underestimated adverse event in cancer patients treated in phase I studiesM Mandalà, F Grosso, C Vitalini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
The impact of cancer treatment guidelines on actual practice in Italian general hospitals: the case of ovarian cancerR Grilli, A Alexanian, G Apolone, et al.
Cancer Treatment Reports|August 1, 1980
Early phase pharmacokinetics of doxorubicin (adriamycin) in plasma of cancer patients during single- or multiple-drug therapyE Piazza, M G Donelli, M Broggini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Critical review of the quality and development of randomized clinical trials (RCTs) and their influence on the treatment of advanced epithelial ovarian cancerS Marsoni, W Torri, A Taiana, et al.
Tumori|June 30, 1990
Quality of care of colorectal cancer patients in general hospitals: diffusion and impact of management guidelinesG Apolone, R Grilli, A A Alexanian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2018
Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancerS Siena, A Sartore-Bianchi, S Marsoni, et al.
Pageof 7